Coexpression of CD44 variant isoforms and receptor for hyaluronic acid−mediated motility (RHAMM, CD168) is an International Prognostic Index and C-MYC gene status−independent predictor of poor outcome in diffuse large B-cell lymphomas-Reference-Cited by-同舟云学术

Coexpression of CD44 variant isoforms and receptor for hyaluronic acid−mediated motility (RHAMM, CD168) is an International Prognostic Index and C-MYC gene status−independent predictor of poor outcome in diffuse large B-cell lymphomas

Published:2010-01 Issue:1 Volume:38 Page:38-45
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Nagel Sabine,Hirschmann Petra,Dirnhofer Stephan,Günthert Ursula,Tzankov Alexandar

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference43 articles.

1. Diffuse large B-cell lymphoma, not otherwise specified;Stein,2008

2. Variability in immunophenotype in diffuse large B-cell lymphoma and its clinical relevance;de Leval;Histopathology,2003

3. Molecular pathogenesis of diffuse large B-cell lymphoma;Lossos;J Clin Oncol,2005

4. Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma;Muris;J Pathol,2006

5. Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification;Pileri;Histopathology,2002

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RHAMM marks proliferative subpopulation of human colorectal cancer stem cells;Cancer Science;2023-03-31

2. Pre-treatment neutrophil-lymphocyte and monocyte-lymphocyte ratios give clues about response, survival, and recurrence in diffuse large B-cell lymphoma;Archive of Oncology;2023

3. Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients;Cancers;2022-03-04

4. The cell cycle‐related genes RHAMM, AURKA, TPX2, PLK1, and PLK4 are associated with the poor prognosis of breast cancer patients;Journal of Cellular Biochemistry;2022-01-10

5. Extracellular matrix and its therapeutic potential for cancer treatment;Signal Transduction and Targeted Therapy;2021-04-23